Form 4 holding
CMO
Edgewise Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 32,500
- Estimated value
- $437,294
- Report date
- 12 Aug 2026
- Price
- $18.91
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount